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a b s t r a c t
Background: Tissue culture and histopathology are the conventional diagnostic modalities for skin and
soft tissue infections (SSTIs), but few studies have investigated their concordance.
Objective: Determine concordance between histopathology and tissue culture in the diagnosis of suspected SSTIs.
Methods: Single-center retrospective study of 355 cases with suspected SSTIs identified from the dermatology inpatient consultation log January 2014-July 2017.
Results: Overall concordance between histopathology testing and tissue culture results was high (76.1%).
Concordance was high for cases defined as no evidence of infection, fungal infection and mycobacterial
infection by histopathology (77.8%, 74.2%, and 80.0%) and tissue culture (92.1%, 67.7%, and 83.3%).
Concordance was lower for suspected SSTIs with bacterial infection by histopathology (61.9%) and tissue
culture (28.4%). Concordance rates were not significantly affected by age, sex, race, antimicrobial agent
use, immunologic status, or biopsy size.
Limitations: Retrospective and single-institution nature of the study.
Conclusion: This study demonstrated a high concordance between histopathology and tissue culture in
SSTIs with no clinical evidence of infection and suspected fungal and mycobacterial SSTIs, though concordance was lower for suspected SSTIs with evidence of bacterial infection. Clinicians should not be
deterred from relying on initial histopathological results based on patients’ immunosuppressed status,
antimicrobial agent use, age, or biopsy tissue size.
Ó 2020 Published by Elsevier Inc. on behalf of Women’s Dermatologic Society. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction
Skin and soft tissue infections (SSTIs) affect approximately 7% to
10% of hospitalized patients and account for 6.3 million physician
office visits per year (Ki and Rotstein, 2008; Stevens et al., 2014).
Although SSTIs often remain mild, superficial SSTIs may progress
to systemic and even fatal infections over days, particularly in
immunosuppressed patients (Gonzalez Santiago et al., 2014; Ki
and Rotstein, 2008). Therefore, a timely diagnosis and pathogen
classification is essential for early and targeted treatment
(Esposito et al., 2016).
⇑ Corresponding author.

The variable clinical presentations of SSTIs pose a challenge to
clinical diagnosis, often resulting in a reliance on microbiological
studies. A histopathologic examination and tissue culture are the
conventional diagnostic techniques for SSTIs (Stevens et al.,
2014). Histopathology testing provides rapid identification of the
pathogen but requires trained personnel. Tissue culture provides
more specific characterization of the pathogen and its sensitivities
to medications but its use is limited by the prolonged turnaround
time and its inability to cultivate some pathogens (Drinka et al.,
2012; Guarner and Brandt, 2011). Tissue culture testing is considered the gold standard for SSTIs (Fan et al., 2017). As a result, tissue
cultures are often run concurrently with histopathological examinations in clinical practice (Woods and Walker, 1996).
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Although past studies have focused on the utility of the
individual diagnostic tests, a limited number of studies have
questioned their concordance and, in turn, the necessity of
performing both diagnostic tests in the setting of suspected
SSTIs. In an effort to reduce patient morbidity and costs
from unnecessary procedures, we evaluated the concordance of
histopathology testing and tissue culture results of suspected
SSTIs.

Results
Demographic, medical, and diagnostic variables
Details of the demographic, health, and diagnostic variables and
the subclassification of the histopathology results and tissue culture are presented in Table 1. Of a total of 355 patients, 252 were
immunosuppressed (70.99%) and 303 were on antimicrobial treatments (85.35%; Table 1). The median age was 58 years (interquartile range, 26).

Methods
Concordance

Approval was obtained from the institutional review board at
Washington University in St. Louis, Missouri. Cases of suspected
SSTIs were identified from the log of inpatient consultations seen
by the dermatology service between January 2014 and July 2017
at Barnes Jewish Hospital in St. Louis, Missouri. Cases with tissue
culture and a concurrent histopathological examination were
included. Viral infections and cases with insufficient documentation were excluded.
Demographic, microbiological, and clinical variables were collected retrospectively from clinical records. Biopsy tissue size
was categorized as 4 mm and 5 mm. Antimicrobial use at the
time of biopsy testing was documented. Cases were considered
immunosuppressed if a patient had a history of transplant (solid
and bone marrow transplants), lymphoma or leukemia, primary
malignancies, systemic lupus erythematous, human immunodeficiency virus/acquired immunodeficiency syndrome, lymphoproliferative disorders (e.g., myelodysplastic syndrome), leukopenia,
neutropenia, or pancytopenia.
The primary outcome measure was the concordance rate
between histopathology testing and tissue culture results in the
diagnosis of SSTIs. Concordance was defined as the rate of agreement between the diagnostic modalities on the presence and type
of infection, subclassified into bacterial, fungal, and mycobacterial,
calculated based on the number of concordant cases divided by the
total number of cases (concordant + discordant). Tissue cultures
were defined as positive if they grew at least one identifiable
organism and negative if they had no growth, growth of skin flora,
or contamination. Histopathology test results were classified as
positive if the pathologist reported a definitive diagnosis or high
likelihood of infection and negative if the pathologist reported a
low likelihood or no concern for infection. Histopathology results
positive for infection without specification of type or positive for
>1 type of infection were considered concordant with positive tissue cultures. To account for chance, Cohen’s kappa was also
reported.
The secondary outcome measures were the concordance rates
of final clinical diagnosis with tissue culture and histopathology
test results. A final clinical diagnosis was considered concordant
with histopathology and tissue culture results if the final
clinical diagnosis agreed with the tissue culture or histopathology results. Final clinical diagnoses and type of infection were
determined from dermatology, infectious disease, and
discharge summary notes. If the final diagnosis was not clearly
stated in the electronic medical record before patient
discharge or death, the dermatology attending physician retrospectively reviewed the patient chart and determined the final
diagnosis.
Baseline demographic and medical history factors were characterized as frequency distributions and percent of total for nominal
variables, mean and standard deviation for ordinal variables, and
median and interquartile ranges for continuous variables. Baseline
comparisons stratified by concordance status were tested using
v2 for categorical variables and Mann-Whitney for continuous
variables.

The overall concordance between histopathology and tissue
culture results was high for suspected SSTIs (agreement: 76.1%;
Cohen’s kappa: 0.4476 [standard error: 0.352; p < .001]). Notably,
concordance rates were not significantly affected by age
(p = .852), sex (p = .874), race (p = .307), antimicrobial use
(p = .212), immunosuppressed status (p = .235), or tissue biopsy
size (p = .779; Table 1). Concordance between tissue culture and
histopathology differed by the type of infection. There was a high
concordance between tissue culture and histopathology for cases
with no evidence of infection, fungal infection, and mycobacterial
infection by histopathology (77.82%, 74.19%, and 80.00%, respectively) and by tissue culture (92.08%, 67.65%, and 83.33%, respectively; Table 1). Concordance was lower for cases defined as
bacterial infection by histopathology (61.90%) and tissue culture
(28.38%; Table 1). Of the 53 cases with positive bacterial cultures
and discordant histopathology results, the organisms most commonly identified were Staphylococcus aureus (64.15%; 34 of 53
cases) and Pseudomonas aeruginosa (9.43%; 5 of 53 cases). Final
clinical diagnosis had a high concordance with tissue culture
(83.66%) and histopathology (80.00%; Fig. 1).
Discussion
In an effort to reduce patient morbidity and unnecessary cost,
we investigated the necessity of performing both tissue culture
and histopathology testing for suspected SSTIs by examining their
concordance. Our study revealed a 76.1% concordance between tissue culture and histopathological examination of suspected SSTIs,
similar to previously reported data for deep cutaneous fungal
infections and suspected SSTIs in primarily outpatient settings
(Fan et al., 2017; Gonzalez Santiago et al., 2014).
Our findings revealed a high concordance between tissue culture and histopathology testing for suspected SSTIs with no evidence of infection as well as fungal and mycobacterial infection,
indicating a high reliability of microbiological testing for these
types of infections. Therefore, there should be a low threshold to
initiate or change therapy in patients with fungal or mycobacterial
infections based on the results of histopathological testing,
enabling clinicians to take advantage of the rapidity of a
histopathological diagnosis for early initiation and modification
of treatment plans.
However, we found that concordance between tissue culture
and histopathology differed by infection type, with a lower concordance for suspected SSTIs with evidence for bacterial infection. The
higher rates of discordance for bacterial infections may reflect an
increased difficulty in identifying bacterial organisms through
histopathological examination. This may be explained by the low
sensitivity of gram staining for common bacterial SSTIs, particularly after damage to the cell walls of gram-positive organisms
by antimicrobial agents or during tissue processing (Wilson and
Winn, 2008; Woods and Walker, 1996). Alternatively, tissue cultures may have grown bacterial organisms that were not clinically
396
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Table 1
Baseline characteristics and concordance of histopathology and tissue culture results.
Characteristic

All cases
(n = 355)

Tissue culture and histopathology
concordance
Discordant
(n = 85)

Concordant
(n = 270)

p value

58 (41–67)

60 (44–68)

57 (41–67)

.279

Male
Female

202 (56.90)
153 (43.10)

49 (57.65)
36 (42.35)

153 (56.67)
117 (43.33)

.874

Non-Hispanic white
Non-Hispanic black
Other

286 (80.56)
60 (16.90)
9 (2.54)

64 (75.29)
19 (22.35)
2 (2.35)

222 (82.22)
41 (15.19)
7 (2.59)

.307

Antimicrobial medicationsy, n (%)

303 (85.35)

69 (81.18)

234 (86.67)

.212

Immunosuppressedà, n (%)

252 (70.99)

56 (65.88)

196 (72.59)

.235

Tissue biopsy size (mm), mean (standard deviation)

4.69 (1.08)

4.76 (1.22)

4.72 (1.04)

.779

4
5

192 (54.1)
163 (45.9)

46 (54.12)
39 (45.88)

146 (54.07)
124 (45.93)

.994

No infection
Infection
Bacterial infection
Fungal infection
Mycobacterial infection
Multiple infectionsc
Infection, not otherwise specified§

284 (80.00)
71 (20.00)
21 (5.92)
31 (8.73)
5 (1.41)
2 (0.56)
12 (3.38)

63 (22.18)
22 (30.99)
8 (38.10)
8 (25.81)
1 (20.00)
1 (50.00)
4 (33.33)

221 (77.82)
49 (69.01)
13 (61.90)
23 (74.19)
4 (80.00)
1 (50.00)
8 (66.67)

Bacterial culture
Fungal culture
Mycobacterial culture
Multiple infections||Multiple infections||

240 (67.61)
115 (32.39)
74 (20.85)
34 (9.58)
6 (1.69)
1 (0.28)

19 (7.92)
66 (57.39)
53 (71.62)
11 (32.35)
1 (16.67)
1 (100.00)

221 (92.08)
49 (42.61)
21 (28.38)
23 (67.65)
5 (83.33)
0 (0.00)

Age, median (interquartile range)
Sex, n (%)

Race, n (%)

Biopsy tissue size, mm

Histopathology results, n (%)*

–

Tissue culture results, n (%)*
Negative culture
Positive culture

–

*
Frequency of concordant and discordant histopathology and tissue culture results are reported as rows rather than columns.
Some patients (n = 197) were on >1 type of antimicrobial treatment.
à
Immunosuppressed was defined as a history of transplant (solid and bone marrow transplants), lymphoma, leukemia, primary malignancies, systemic lupus erythematous
disorder, human immunodeficiency virus/acquired immunodeficiency syndrome, lymphoproliferative disorders (e.g., myelodysplastic syndrome), leukopenia, neutropenia or
pancytopenia.
§
Positive histopathology results without the specification of type of infection were classified as infection, not otherwise specified.
||
Cases with histopathology or tissue culture reports with >1 type of infection were classified as multiple infections.
y

found that the rates of positive tissue cultures and concordance
rates of tissue culture with histopathology testing did not differ
significantly based on immunosuppressed status or antimicrobial
use. Concordance rates were also not affected by biopsy size or
patient age. Our findings suggest that in most clinical situations,
clinicians should not be deterred from diagnostic and therapeutic
decision-making based on initial histopathological results due to
a patient’s immunosuppressed status, antimicrobial use, age, or
biopsy size, because the concordance of histopathology results
with tissue culture results does not differ based on these
parameters.
Our study is limited because of its retrospective and singleinstitution nature. Retrospective evaluations of a clinical diagnosis
in the absence of a clinical diagnosis in the electronic medical
record is a potential source of misclassification bias. Patients were
identified from the dermatology inpatient consultation log, subjecting our study to a selection bias. Antimicrobial therapy may
have affected the ability to detect infection for both histopathology
testing and tissue culture.

Fig. 1. Overall concordance of tissue culture results, histopathology results, and
final clinical diagnosis on the presence and type of infection of cutaneous lesions.

significant; however, only cultures containing normal skin flora or
containments were considered negative cultures to minimize this
possibility. Overall, the low concordance rates of tissue culture
and histopathology testing for bacterial infections emphasizes
the importance of clinical context in determining the significance
of diagnostic testing for SSTIs in patients with these infections.
Previous studies suggest that tissue cultures in immunosuppressed patients and patients on antimicrobial treatments have
limited diagnostic utility owing to a low yield of true positive cultures (Woods and Walker 1996). In contrast to these studies, we

Conclusion
Our study reveals a high concordance between tissue culture
and histopathology in cases of suspected SSTI. Clinicians should
397
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not be deterred from relying on initial histopathological test
results based on patients’ immunosuppressed status, antimicrobial
use, age, or biopsy size. Our findings suggest that in most clinical
situations, an initial histopathological diagnosis is sufficient for
early initiation and modification of therapy. Future studies should
investigate additional sources of discordance, particularly in suspected SSTIs with evidence of bacterial infection.
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